Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia

Jessica S. Snider, Iya Znoyko, Kathryn G. Lindsey, Jennifer Morse, Linda B. Baughn, Nicole L. Hoppman, Beth A. Pitel, Kathryn E. Pearce, Cynthia A. Schandl, Daynna J. Wolff

Research output: Contribution to journalArticlepeer-review

Abstract

The 2016 World Health Organization entity ‘Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2’ encompasses a group of rare neoplasms that result from the formation of a fusion gene that leads to expression of an aberrant tyrosine kinase. This entity also contains variant JAK2 fusion partners, and detection of this defining event can be facilitated by various cytogenetic and molecular methods. Cryptic rearrangements of 9p24/JAK2 can be particularly challenging to identify. We describe the use of chromosomal microarray analysis (CMA), fluorescence in situ hybridization (FISH) with a probe for JAK2, and genomic mate pair analysis to describe a complex karyotype with a t(9;22) that produced a functional BCR-JAK2 fusion, leading to the appropriate diagnosis for the patient. This case highlights the importance of using an integrated genomic approach to fully define complex aberrations to assign proper diagnoses.

Original languageEnglish (US)
Pages (from-to)44-47
Number of pages4
JournalCancer Genetics
Volume246-247
DOIs
StatePublished - Aug 2020

Keywords

  • Acute leukemia
  • Chromosomal microarray analysis
  • Fluorescence in situ hybridization
  • Mate pair sequencing

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia'. Together they form a unique fingerprint.

Cite this